Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy

Clinical and Experimental Obstetrics and Gynecology

Volumn 39, Issue 2, 2012, Pages 191-194

  Grigoriadis, C ^a   Papaconstantinou, E ^b   Mellou, A ^b   Hassiakos, D ^a   Liapis, A ^a   Kondi Pafiti, A ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

GnRH agonist; Morphological changes; Uterine leiomyomas

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MITOSIS RATE; NECROSIS; PATHOLOGY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; TUMOR VOLUME; UTERUS MYOMA;

ADULT; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYSTERECTOMY; HYSTEROSCOPY; LEIOMYOMA; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 84863608927     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schally A.V., Arimura A., Kastin A., Matsuo H., Baba Y., Redding T.W. et al.: "Gonadotropin releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones". Science, 1971, 173, 1036.
2. Belchetz P.E., Plant T.M., Nakai Y., Keogh E.J., Knobil E.: "Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone". Science, 1978, 202, 631.
3. Kraus S., Naor Z., Seger R.: "Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor". Arch. Med. Res., 2001, 32, 499.
4. Chegini N., Kornberg L.: "Gonadotropin releasing hormone analogues (GnRHa) therapy alters signal transduction pathways involving MAP and focal adhesion kinases in leiomyoma". J. Soc. Gynecol. Invest., 2003, 10, 21.
5. Palmare V., Triolo O., Benedetto V., Lo Re C., Sturlese E., Retto G., Santoro G.: "Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate". Gynecol. Obstet. Invest., 2010, 69, 131.
6. Vercellini P., Trespidi L., Zaina B., Vicentini S., Stellato G., Crosignani P.G.: "Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial". Fertil. Steril., 2003, 79, 1390.
7. Seracchioli R., Venturoli S., Colombo F.M., Bagnoli A., Vinello F., Covoni F. et al.: "GnRH agonist treatment before total laparoscopic hysterectomy for large uteri". J. Am. Ass. Gynecol. Laparosc., 2003, 10, 316.
8. Gudmundsson J.A., Lundkvist O., Berqquist C., Lindgren A., Nillius S.J.: "Endometrial morphology after 6 months of continuous treatment with a new gonadotropin-releasing hormone superagonist for contraception". Fertil. Steril., 1987, 48, 52.
9. Colgan T., Pendergast S., LeBlanc M.: "The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues". Hum. Pathol., 1993, 24, 1073.
10. Upadhyaya N.B., Doody M.C., Googe P.B.: "Histopathological changes in leiomyomata treated with leuprolide acetate". Fertil. Steril., 1990, 54, 811.
11. Mantel W.H.M., Haenszel W.: "Statistical aspects of the analysis of data from retrospective studies of disease". J. Natl. Cancer Inst., 1959, 22, 719.
12. Stovall T.G., Ling F.W., Henry L.C., Woodruff M.R.: "A randomized trial evaluation of leuprolide acetate before hysterectomy as treatment for leiomyomas". Am. J. Obstet. Gynecol., 1991, 164, 1420.
13. Friedman A.J., Barbieri R.L.: "Leuprolide acetate: Application in gynecology". Curr. Prob. Obstet. Gynecol. Fertil., 1988, 11, 209.
14. Letterie G.S., Coddington C.C., Winkel C.A., Shawker T.H., Loriaux D.L., Collins R.L.: "Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long term follow-up". Fertil. Steril., 1989, 51, 951.
15. Schlaff W.D., Zerhouni E.A., Huth J.A., Chen J., Damewood M.D., Rock J.A.: "A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata". Obstet. Gynecol., 1989, 74, 856.
16. Khan K.N., Kitajima M., Hiraki K., Fujishita A., Sekine I., Ishimaru T., Masuzaki H.: "Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy". Hum. Reprod., 2010, 25, 642.
17. Friedman A.J., Lobel S.M., Rein M.S., Barbieri R.L.: "Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis". Am. J. Obstet. Gynecol., 1990, 163, 1114.